Rapport Therapeutics IPO

Rapport Therapeutics is discovering and developing novel therapies targeting G protein-coupled receptors (GPCRs)

Register for Details

For more details on financing and valuation for Rapport Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Rapport Therapeutics's ticker symbol?

Rapport Therapeutics does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is Rapport Therapeutics's stock price?

The stock price for Rapport Therapeutics will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Rapport Therapeutics Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
8/7/2023 Series B $150MM raised $XXX.XX $XXX.XX
3/7/2023 Series A $100.18MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Rapport Therapeutics

Forge green plus iconForge green minus icon

What is Rapport Therapeutics funding to date?

Rapport Therapeutics has raised $250.18MM to date.
Forge green plus iconForge green minus icon

When was Rapport Therapeutics founded?

Rapport Therapeutics was founded in 2022.
Forge green plus iconForge green minus icon

Can you invest in Rapport Therapeutics?

Rapport Therapeutics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Rapport Therapeutics share pre-IPO?

If you own Rapport Therapeutics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Rapport Therapeutics a publicly traded company?

Rapport Therapeutics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Other companies like Rapport Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$3.45B
Sector
Last Round Est. Valuation
$656.14MM
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$705.25MM
Sector
Last Round Est. Valuation
$1.15B
Sector
Last Round Est. Valuation
$1.22B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Updated on: Sep 12, 2023

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.